Adjuvant chemotherapy and survival outcomes in rectal cancer patients with good response (ypT0-2N0) after neoadjuvant chemoradiotherapy and surgery: A retrospective nationwide analysis

BACKGROUND: For rectal cancer, it remains unclear how to incorporate tumor response to neoadjuvant chemoradiotherapy (nCRT) when deciding whether to give adjuvant chemotherapy. In this study, we aim to determinate the survival benefit of adjuvant chemotherapy for rectal cancer patients with good res...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Yu-Hsuan, Lin, Yun-Tzu, Ho, Chung-Han, Chou, Chia-Lin, Cheng, Li-Chin, Tsai, Chia-Jen, Hong, Wei-Ju, Chen, Yi-Chen, Yang, Ching-Chieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800595/
https://www.ncbi.nlm.nih.gov/pubmed/36591443
http://dx.doi.org/10.3389/fonc.2022.1087778

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800595/
https://www.ncbi.nlm.nih.gov/pubmed/36591443
http://dx.doi.org/10.3389/fonc.2022.1087778

Ejemplares similares